Skip to Main Content

An official website of the United States government

Use of Breast Cancer Risk Reducing Medications

Principal Investigator
Name
Paul Pinsky
Institution
National Institutes of Health
Position Title
Chief, EDRG
Email
About this CDAS Project
Study
PLCO (Learn more about this study)
Project ID
PLCO-1749
Initial CDAS Request Approval
Nov 19, 2024
Title
Use of Breast Cancer Risk Reducing Medications
Summary
Assess the use of breast cancer risk reducing medications by breast cancer risk, calendar year, and other factors.
Aims

Compute rates of breast cancer risk reducing medications by breast cancer risk level.

Compute rate of breast cancer risk reducing medications by calendar year

Collaborators

None

Related Publications